Filter
1765
Filtered Results: 1765
Text search:
Pharmaceutical
Assessment
Featured
Recommendations
163
New Publications
468
Language
Document type
No document type
938
Studies & Reports
334
Guidelines
259
Manuals
87
Strategic & Response Plan
78
Fact sheets
23
Training Material
21
Situation Updates
14
Resource Platforms
5
Brochures
3
Infographics
2
Online Courses
1
Countries / Regions
India
72
Ethiopia
71
Kenya
68
Global
61
Nigeria
41
South Africa
40
Western and Central Europe
39
Uganda
39
Liberia
36
Sierra Leone
32
Ghana
29
Rwanda
28
Tanzania
26
Namibia
26
Ukraine
25
Nepal
24
Zambia
24
Malawi
23
Bangladesh
21
Philippines
19
Eastern Europe
19
Africa
18
Cambodia
16
Latin America and the Carribbean
16
Lesotho
14
Zimbabwe
14
Syria
13
Myanmar / Burma
13
South–East Asia Region
10
West and Central Africa
9
Indonesia
9
Eswatini/ Swaziland
9
Cameroon
8
Senegal
8
Botswana
8
Congo, Democratic Republic of
7
Eastern Europe and Central Asia
7
East and Southern Africa
7
Thailand
6
Asia
6
Russia
6
South Sudan
6
Benin
5
Albania
5
Burkina Faso
5
Guinea
5
Germany
5
Mozambique
4
Haiti
4
Middle East and North Africa
4
Western Pacific Region
4
Vietnam
4
Brazil
4
Pakistan
4
Laos
3
USA
3
Venezuela
3
Jordan
3
North America
3
United Kingdom
3
Lebanon
3
Papua New Guinea
3
North Macedonia
2
China
2
Fiji
2
Peru
2
Lithuania
2
Jamaica
2
Moldova
2
Egypt
2
Sudan
2
Yemen
2
Central African Republic
2
Mali
2
Iraq
2
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Chile
1
Canada
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Spain
1
Southern Africa
1
Bolivia
1
Romania
1
Palestine
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
748
Clinical Guidelines
127
Public Health
93
Key Resources
67
Women & Child Health
43
Pharmacy & Technologies
25
Capacity Building
13
Annual Report MEDBOX
1
Toolboxes
AMR
162
COVID-19
150
Pharmacy
135
Mental Health
108
TB
81
HIV
80
Rapid Response
55
Planetary Health
49
NCDs
46
NTDs
34
Ebola
32
Caregiver
32
Conflict
32
Global Health Education
27
Health Financing Toolbox
19
Specific Hazards
14
Disability
13
Polio
10
Refugee
9
Natural Hazards
7
Cholera
2
Social Ethics
2
South Sudan
1
Health Financing
1
Zika
1
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
Reporting period January 2015 – December 2015
Bucharest, April 2016
This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
This book provides significantly expanded content and experience in relation to a broader stewardship context- for example, stewardship in specific populations, different countries as well as the role of different professions in stewardship to political and media engagement. We hope this book has so...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
How we respond both now and going forward will help mitigate the impact of COVID-19, and to the extent possible preserve children’s rights to Survive, Learn, and Be Protected. We will focus our efforts on the most critical work essential to maintaining these commitments to the extent possible.
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a...
Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020.
This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Accessed on 31.03.2020
This Guidance Note aims to provide humanitarian child protection practitioners, particularly child protection advisors and program managers, with guidance on how to engage in responses to infectious disease outbreaks to ensure children’s protection needs are taken into ac...
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
The ECA, says over 300,000 Africans could lose their lives due to COVID-19. This, as the pandemic continues to impact on the Continent’s struggling economies whose growth is expected to slow down from 3.2 percent to 1.8 percent in a best-case scenario, pushing close to 27 million people into extr...
